BACKGROUND: In 2011, seventeen years after the first national study on the prevalence of nosocomial infections and antibiotic use in German hospitals, a second national prevalence study was carried out according to the specifications of the European Centre for Disease Prevention and Control (ECDC). METHODS: The ECDC protocol, containing uniform surveillance definitions and ascertainment methods, was implemented. The only infections counted were those that were active or under treatment with antibiotics on the day of the study. In addition to the representative sample required by the ECDC, which consisted of 46 hospitals, further hospitals participated on a voluntary basis. RESULTS: Data on 41 539 patients in 132 hospitals were analyzed. The prevalence of infections that had arisen during the current hospital stay was 3.8% in the overall group and 3.4% in the representative sample of 9626 patients in 46 hospitals. The prevalence of all nosocomial infections, including those acquired before the current hospital stay and still present upon admission, was 5.1% in both the overall group and the representative sample. The prevalence of antibiotic use on the day of the study was 25.5% and 23.3% in the two groups, respectively. CONCLUSION: The prevalence of nosocomial infection has not changed since 1994, but the prevalence of antibiotic use has increased. In interpreting these findings, one should bear in mind that confounders may have influenced them in different directions: The mean length of hospital stay is now shorter than in 1994, but the mean age of hospitalized patients is higher.
BACKGROUND: In 2011, seventeen years after the first national study on the prevalence of nosocomial infections and antibiotic use in German hospitals, a second national prevalence study was carried out according to the specifications of the European Centre for Disease Prevention and Control (ECDC). METHODS: The ECDC protocol, containing uniform surveillance definitions and ascertainment methods, was implemented. The only infections counted were those that were active or under treatment with antibiotics on the day of the study. In addition to the representative sample required by the ECDC, which consisted of 46 hospitals, further hospitals participated on a voluntary basis. RESULTS: Data on 41 539 patients in 132 hospitals were analyzed. The prevalence of infections that had arisen during the current hospital stay was 3.8% in the overall group and 3.4% in the representative sample of 9626 patients in 46 hospitals. The prevalence of all nosocomial infections, including those acquired before the current hospital stay and still present upon admission, was 5.1% in both the overall group and the representative sample. The prevalence of antibiotic use on the day of the study was 25.5% and 23.3% in the two groups, respectively. CONCLUSION: The prevalence of nosocomial infection has not changed since 1994, but the prevalence of antibiotic use has increased. In interpreting these findings, one should bear in mind that confounders may have influenced them in different directions: The mean length of hospital stay is now shorter than in 1994, but the mean age of hospitalized patients is higher.
Authors: Keith S Kaye; Kristine Schmit; Carl Pieper; Richard Sloane; Kathleen F Caughlan; Daniel J Sexton; Kenneth E Schmader Journal: J Infect Dis Date: 2005-02-24 Impact factor: 5.226
Authors: P Gastmeier; M Behnke; A-C Breier; B Piening; F Schwab; M Dettenkofer; C Geffers Journal: Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz Date: 2012-11 Impact factor: 1.513
Authors: Jean Carlet; Vincent Jarlier; Stephan Harbarth; Andreas Voss; Herman Goossens; Didier Pittet Journal: Antimicrob Resist Infect Control Date: 2012-02-14 Impact factor: 4.887
Authors: Thomas von Lengerke; Bettina Lutze; Christian Krauth; Karin Lange; Jona Theodor Stahmeyer; Iris Freya Chaberny Journal: Dtsch Arztebl Int Date: 2017-01-20 Impact factor: 5.594
Authors: Marcel Hochreiter; Maria Uhling; Leila Sisic; Thomas Bruckner; Alexandra Heininger; Andreas Hohn; Katja Ott; Thomas Schmidt; Marc Moritz Berger; Daniel Christoph Richter; Markus Büchler; Markus Alexander Weigand; Cornelius Johannes Busch Journal: Infection Date: 2018-06-05 Impact factor: 3.553
Authors: Jens Hachenberg; Christian Eichler; Ellen Acis; Maximilian Mattes Auer-Schmidt; Mathias Warm; Wolfram Malter; Fabinshy Thangarajah Journal: In Vivo Date: 2021 Jan-Feb Impact factor: 2.155